Skip to content

Hypoalbuminemia in Mild Acute Stroke and Cognitive Impariment Post-stroke

Relationship Between Baseline Serum Albumin Level and Cognitive Impariment in Mild Acute Ischemic Stroke

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04135872
Enrollment
435
Registered
2019-10-23
Start date
2017-01-01
Completion date
2018-08-30
Last updated
2019-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Albumin; Double, Cognitive Impairment, Stroke

Brief summary

This registration enrolled patients with acute ischemic stroke within 72 hours after stroke ictus. Patients was identified as first-ever stroke based on past medical histrory. Admission CT was conducted to exclude hemorrhagic stroke, but not those bleeding transformation after ischemia injury. Baseline characteristics, including demographics, vascular risk factors, lab tests and neuroimagings were collected. Patients were followed up for cognitive assessments.

Detailed description

This is a perspective stroke registry cohort study. Stroke patients were included if :(1) acute first-ever ischemic stroke and admitted within 72 hours after onset; (2) clinical stroke diagnosis was confirmed with positive diffusion-weighted magnetic resonance imaging (DW-MRI), those with isolated posterior circulations infarcts were exclude ; (3) presented with mild stroke severity ( admission NIHSS score ≤5); (4) age between 40 and 80 years. Clinical data including demographic characteristics, risk factors, and baseline NIHSS score were assessed and collected using a standardized table by experienced neurologists. Lab tests were performed with fasting venous blood samples within 18 hours of admission. Patients were followed up for 6 months. The cognitive functions were assessed using the Chinese version of Montreal Cognitive Assessment (MoCA). Contributing factors to post-stroke cognitive impariment (PSCI) were determined by comparing clinical data between PSCI and non-PSCI groups. All potential confounders were introduced into the multivariate regression models.

Interventions

OTHERstrengthened nuitritional treatment

improving nutritional status by nasal feeding for dysphagia or iv. albumin when serum albumin level lower than 35g/L

Sponsors

Dongguan People's Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years

Inclusion criteria

1. acute first-ever ischemic stroke and admitted within 72 hours after onset; 2. clinical stroke diagnosis was confirmed with positive diffusion-weighted magnetic resonance imaging (DW-MRI), those with isolated posterior circulations infarcts were exclude ; 3. presented with mild stroke severity ( admission NIHSS score ≤5); 4. age between 40 and 80 years.

Exclusion criteria

1. Patients with index cognitive impairment or under current anti-dementia or psychiatric medication; 2. patients with large infarcts (≥1/3 middle cerebral artery territory); 3. patients with severe language or physical disability that impede neuropsychological testing; 4. patients with recurrent transient ischemic attack (TIA)/stroke during follow-up; 5. coexisting serious conditions known to impair cognitive function

Design outcomes

Primary

MeasureTime frameDescription
PSCI6 months post-strokePatients with a MoCA score of \<24 were categorized as having PSCI

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026